Leap Therapeutics, Inc.

Informe acción NasdaqCM:LPTX

Capitalización de mercado: US$84.2m

Salud financiera de hoja de balance de Leap Therapeutics

Salud financiera controles de criterios 6/6

Leap Therapeutics tiene un patrimonio de los accionistas total de $60.1M y una deuda total de $0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son $72.8M y $12.7M respectivamente.

Información clave

0%

Ratio deuda-patrimonio

US$0

Deuda

Ratio de cobertura de interesesn/a
EfectivoUS$54.92m
PatrimonioUS$47.37m
Total pasivoUS$10.59m
Activos totalesUS$57.96m

Actualizaciones recientes sobre salud financiera

Recent updates

Is Leap Therapeutics (NASDAQ:LPTX) In A Good Position To Deliver On Growth Plans?

Mar 13
Is Leap Therapeutics (NASDAQ:LPTX) In A Good Position To Deliver On Growth Plans?

Will Leap Therapeutics (NASDAQ:LPTX) Spend Its Cash Wisely?

Nov 22
Will Leap Therapeutics (NASDAQ:LPTX) Spend Its Cash Wisely?

Leap Therapeutics GAAP EPS of -$0.15 misses by $0.05

Aug 12

Leap Therapeutics begins trials of DKN-01 in gastric/colorectal cancers

Jul 12

Leap Therapeutics: 2 Catalysts With Cancer Drug DKN-01 In The 2nd Half Of 2022

Jun 27

Here's Why We're Watching Leap Therapeutics' (NASDAQ:LPTX) Cash Burn Situation

May 01
Here's Why We're Watching Leap Therapeutics' (NASDAQ:LPTX) Cash Burn Situation

Leap Therapeutics: Waiting For One More Leap

Feb 18

We're Hopeful That Leap Therapeutics (NASDAQ:LPTX) Will Use Its Cash Wisely

Jan 04
We're Hopeful That Leap Therapeutics (NASDAQ:LPTX) Will Use Its Cash Wisely

Leap Therapeutics: What Prompted Prioritizing This Precision Oncology Company?

Nov 29

Leap Therapeutics: All On The Line

Oct 13

Is Leap Therapeutics (NASDAQ:LPTX) In A Good Position To Invest In Growth?

Sep 15
Is Leap Therapeutics (NASDAQ:LPTX) In A Good Position To Invest In Growth?

Is Leap Therapeutics (NASDAQ:LPTX) In A Good Position To Invest In Growth?

Jun 01
Is Leap Therapeutics (NASDAQ:LPTX) In A Good Position To Invest In Growth?

Companies Like Leap Therapeutics (NASDAQ:LPTX) Are In A Position To Invest In Growth

Mar 03
Companies Like Leap Therapeutics (NASDAQ:LPTX) Are In A Position To Invest In Growth

Could The Leap Therapeutics, Inc. (NASDAQ:LPTX) Ownership Structure Tell Us Something Useful?

Jan 27
Could The Leap Therapeutics, Inc. (NASDAQ:LPTX) Ownership Structure Tell Us Something Useful?

Announcing: Leap Therapeutics (NASDAQ:LPTX) Stock Increased An Energizing 127% In The Last Year

Dec 23
Announcing: Leap Therapeutics (NASDAQ:LPTX) Stock Increased An Energizing 127% In The Last Year

Need To Know: Analysts Are Much More Bullish On Leap Therapeutics, Inc. (NASDAQ:LPTX)

Nov 18
Need To Know: Analysts Are Much More Bullish On Leap Therapeutics, Inc. (NASDAQ:LPTX)

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($71.6M) de LPTX superan a sus pasivos a corto plazo ($12.7M).

Pasivo a largo plazo: Los activos a corto plazo de LPTX ($56.2M) superan a sus pasivos a largo plazo ($154.0K).


Historial y análisis de deuda-patrimonio

Nivel de deuda: LPTX está libre de deudas.

Reducción de la deuda: LPTX no tenía deudas hace 5 años.


Hoja de balance


Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: LPTX tiene suficiente cash runway para más de un año basándose en su flujo de caja libre actual.

Pronóstico de cash runway: Se prevé que LPTX disponga de suficiente cash runway para 12 meses según las estimaciones de flujo de caja libre, aunque ha obtenido desde entonces capital adicional.


Descubre empresas con salud financiera